Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors

Completed

Conditions studied: Arthralgia, Breast Cancer

In brief

RATIONALE: Gathering information over time about joint pain and stiffness from postmenopausal women with early-stage breast cancer who are receiving aromatase inhibitors may help doctors plan treatment and help patients live more comfortably. PURPOSE: This observational epidemiologic cohort is designed to study arthralgia, patient-reported outcomes, and medication adherence in postmenopausal women with early-stage breast cancer who are receiving aromatase inhibitors.

Key facts

Study ID

NCT00954564

Run by

Vanderbilt University Medical Center

People needed

351

Starts

2009-06-01

Expected to finish

2014-05-01

Last updated by the study team

2017-04-04

Who can join

Age: 35 and older, up to 90. Sex: female. Healthy volunteers: accepted.

Where it is running

• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States
• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.